Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Dementia, particularly Alzheimer's disease (AD), presents a growing global health challenge characterized by cognitive decline, behavioral changes, and loss of independence. With increasing life expectancy, early diagnosis and improved clinical strategies are urgently needed. This study developed and evaluated machine learning (ML) models to predict AD risk using UK Biobank data, integrating healt...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder with increasing prevalence among the ageing population, necessitating early and accurate diagnosis for effective disease management. In this study, we present a novel hybrid deep learning framework, AlzhiNet, that integrates both 2D convolutional neural networks (2D-CNNs) and 3D convolutional neural networks (3D-CNNs), along with...
INTRODUCTION: Type 2 diabetes (T2D) significantly increases dementia risk, yet the molecular mechanisms underlying this association remain unclear. OB...
Alzheimer's disease is a neurodegenerative disorder that leads to progressive memory loss, cognitive decline, and behavioral changes. Despite ongoing ...
Background: Although primarily characterised as a motor disorder, Parkinson's Disease (PD) also presents with non-motor symptoms, including cognitive ...
BACKGROUND: Fingernail metabolomics provides a novel, non-invasive platform that captures long-term biochemical fluctuations for identifying reliable ...
Accurate and early diagnosis of Alzheimer's Disease (AD) is crucial for timely interventions and treatment advancement. Functional Magnetic Resonance ...
Dementia represents a rapidly rising global health challenge as a progressive neurodegenerative disease with few options for disease-modifyingtreatmen...
Recent advances in our understanding of non-cell-autonomous mechanisms in neurodegenerative diseases (NDDs) have highlighted microglial dysfunction as...
Traditional fluorescence lifetime imaging (FLIM) provides valuable quantitative insights for biomedical and molecular biology research, but often reli...
Parkinson's disease (PD) is a prevalent neurodegenerative disorder worldwide, often progressing to mild cognitive impairment (MCI) and dementia. Clini...
The progression of Alzheimer's disease is relentless, leading to a worsening of mental faculties over time. Currently, there is no remedy for this ill...
Dementia is a degenerative and chronic disorder, increasingly prevalent among older adults, posing significant challenges in providing appropriate car...
Language difficulties are common in school-age children but their etiology is often unknown. Although neural underpinnings of language have been well-...
Process scores in neuropsychological tests add incremental validity for detecting non-normative cognitive aging trajectories. However, process scores...
Dementia, a neurological disorder, can cause cognitive decline due to damage to the brain. Our study aims to contribute to the development of computer...
Dipeptidyl peptidase-IV (DPP-IV) inhibitors play a critical role in the treatment of diabetes and metabolic diseases. This study combines computationa...
Alzheimer's Disease (AD) is a progressive neurodegenerative disorder marked by neuronal loss, leading to cognitive and behavioral decline. With the ag...
Neurological diseases, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis, pose a significant global health challenge due to t...
BACKGROUND: Delays in the diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) contribute to the significant morbidity of the condition, especi...